Biotechnology Companies By Current Asset

Current Asset
Current AssetEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
38.52 B
(0.15)
 1.41 
(0.21)
2ABBV AbbVie Inc
16.31 B
(0.01)
 1.28 
(0.02)
3GMAB Genmab AS
12.65 B
 0.01 
 1.94 
 0.01 
4DNA Ginkgo Bioworks Holdings
10.07 B
(0.14)
 5.25 
(0.73)
5BIIB Biogen Inc
8.73 B
(0.14)
 1.76 
(0.25)
6GRFS Grifols SA ADR
3.09 B
(0.04)
 5.40 
(0.23)
7REGN Regeneron Pharmaceuticals
2.92 B
(0.12)
 0.89 
(0.11)
8BEAM Beam TherapeuticsInc
2.89 B
(0.06)
 5.49 
(0.30)
9DYN Dyne TherapeuticsInc
1.93 B
 0.09 
 3.95 
 0.34 
10IMAB I Mab
1.51 B
(0.02)
 3.96 
(0.07)
11VRTX Vertex Pharmaceuticals
1.41 B
(0.12)
 1.17 
(0.14)
12UTHR United Therapeutics
1.28 B
 0.08 
 1.56 
 0.13 
13GRI GRI Bio
1.22 B
(0.28)
 8.61 
(2.41)
14GILD Gilead Sciences
1.18 B
(0.25)
 1.10 
(0.28)
15ALNY Alnylam Pharmaceuticals
1.11 B
(0.16)
 2.11 
(0.35)
16BMRN Biomarin Pharmaceutical
1.09 B
(0.09)
 1.76 
(0.16)
17INCY Incyte
842.38 M
(0.18)
 1.33 
(0.24)
18IONS Ionis Pharmaceuticals
837 M
(0.19)
 1.81 
(0.34)
19ALKS Alkermes Plc
754.96 M
(0.06)
 2.88 
(0.18)
20ACAD ACADIA Pharmaceuticals
603.49 M
(0.24)
 3.06 
(0.74)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets. Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.